TABLE 1.
Clinical and treatment characteristics
| Definitive | Adjuvant | Salvage | Palliative | ||
|---|---|---|---|---|---|
| Age | 65 (±23.4) a | 54 (±16.6) | 62 (±10.0) | 58 (±13.5) | |
| Gender | Male | 5 (71.4) b | 15 (55.6) | 4 (57.1) | 12 (66.7) |
| Female | 2 (28.6) | 12 (44.4) | 3 (42.9) | 6 (33.3) | |
| Histopathology | DTC | 4 (57.1) | 3 (11.1) | 4 (57.1) | 11 (61.1) |
| PDTC | 1 (14.3) | 1 (3.7) | 1 (14.3) | 3 (16.7) | |
| MTC | 0 | 10 (37) | 2 (28.6) | 2 (28.6) | |
| ATC | 2 (28.6) | 13 (48.1) | 0 | 1 (5.6) | |
| Staging | II | 0 | 0 | 0 | 3 (16.7) |
| III | 0 | 1 (3.7) | 0 | 0 | |
| IVa | 0 | 17 (63) | 1 (14.3) | 0 | |
| IVb | 6 (85.7) | 8 (29.6) | 3 (42.9) | 1 (5.6) | |
| IVc | 1 (14.3) | 1 (3.7) | 3 (42.9) | 14 (77.8) | |
| History of RAI | 0 | 3 (11.1) | 4 (57.1) | 5 (27.8) | |
| Median RT total dose | 60 (40–60) c | 60 (54–60) | 60 (56–66) | 30 (30–40) | |
a
Mean (standard deviation).
b
Number (%).
c
Median (IQR).